Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

NCT07549464 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: PLM-102

Sponsor

M.D. Anderson Cancer Center